摘要
<正>1文献来源Maus MKH,Mack PC,Astrow SH,et al.Histology-related associations of ERCC1,RRM1,and TS biomarkers in patients with non-small-cell lung cancer:Implications for therapy[J].J Thorac Oncol,2013,8(5):582-586.2证据水平4。3背景肺鳞状细胞癌(squamous cell carcinoma,SCCA)和肺腺癌(adenocarcinoma,AC)患者的化疗疗效存在差异,而这种差异可能和核苷酸切除修
学科与关键词
关键词
非小细胞肺癌生物标志物个体化治疗核苷酸切除修复交叉互补基因1核糖核苷酸还原酶M1胸苷酸合成酶 non-small cell lung cancerbiomarkerspersonalized treatmentexcision repair cross-complementation group 1(ERCC1)ribonucleotide reductase M1(RRM1)thymidylate synthase(TS)
- 非小细胞肺癌组织中ERCC1和RRM1表达与抗肿瘤治疗的疗效及预后关系李竟长; 倪秉强; 陈日新; 朱州实用临床医药杂志, 2013, (01): 21-23.
- 非小细胞肺癌组织RRM1 mRNA表达及其临床意义何中杰; 冷雪峰; 阳诺; 冼磊广西医学, 2013, (09): 1132-1134.
- DNA修复基因ERCC1多态性与肺癌易感性的关系张增利; 周彩存; 张颉; 唐亮; 粟波Chinese Journal of Lung Cancer, 2008, (02): 183-188.
